Nadia Birocco

Summary

Country: Italy

Publications

  1. pmc Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study
    Alfredo Berruti
    Oncologia Medica, Dipartimento di Specialità Medico Chirurgiche, Scienze Radiologiche e Sanità Pubblica, Universita degli Studi di Brescia, Azienda Ospedaliera Spedali Civili Piazzale Spedali Civili 1, 25123 Brescia, Italy
    BMC Cancer 14:184. 2014
  2. ncbi request reprint The effects of Reiki therapy on pain and anxiety in patients attending a day oncology and infusion services unit
    Nadia Birocco
    SC Oncologia Medica, San Giovanni Battista Hospital, Turin, Italy
    Am J Hosp Palliat Care 29:290-4. 2012
  3. pmc Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network
    Maria P Brizzi
    Oncologia Medica, Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, Azienda Ospedaliera San Luigi, Regione Gonzole, 10, 10043 Orbassano TO, Italy
    BMC Cancer 9:388. 2009

Collaborators

  • Alfredo Berruti
  • Marco Volante
  • Luigi Dogliotti
  • Anna Ferrero
  • Mauro Papotti
  • Maria P Brizzi
  • Lisa Bodei
  • Vito Amoroso
  • Antonio D'Avolio
  • Nicola Fazio
  • Maria Pia Brizzi
  • Guido Biasco
  • Lucia Tozzi
  • Adriano Massimiliano Priola
  • Elisabetta Nobili
  • Mirella Torta
  • Oscar Bertetto
  • Davide Perroni
  • Sebastiano Bombaci
  • Benedetta Ferretti
  • Enrica Milanesi
  • Libero Ciuffreda
  • Oscar Alabiso
  • Federico Castiglione

Detail Information

Publications3

  1. pmc Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study
    Alfredo Berruti
    Oncologia Medica, Dipartimento di Specialità Medico Chirurgiche, Scienze Radiologiche e Sanità Pubblica, Universita degli Studi di Brescia, Azienda Ospedaliera Spedali Civili Piazzale Spedali Civili 1, 25123 Brescia, Italy
    BMC Cancer 14:184. 2014
    ....
  2. ncbi request reprint The effects of Reiki therapy on pain and anxiety in patients attending a day oncology and infusion services unit
    Nadia Birocco
    SC Oncologia Medica, San Giovanni Battista Hospital, Turin, Italy
    Am J Hosp Palliat Care 29:290-4. 2012
    ..32 (P = .091). Overall, the sessions were felt helpful in improving well-being, relaxation, pain relief, sleep quality and reducing anxiety. Offering Reiki therapy in hospitals could respond to patients' physical and emotional needs...
  3. pmc Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network
    Maria P Brizzi
    Oncologia Medica, Dipartimento di Scienze Cliniche e Biologiche, Universita di Torino, Azienda Ospedaliera San Luigi, Regione Gonzole, 10, 10043 Orbassano TO, Italy
    BMC Cancer 9:388. 2009
    ..A phase II study was designed to test the activity of protracted 5-fluorouracil (5FU) infusion plus long-acting release (LAR) octreotide in patients with neuroendocrine carcinoma...